The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer

被引:4
|
作者
Johnstone, Mark S. [1 ,2 ]
Mcsorley, Steven T. [1 ]
Mcmillan, Donald C. [1 ]
Horgan, Paul G. [1 ]
Mansouri, David [1 ]
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Acad Unit Surg, Glasgow, Scotland
[2] Glasgow Royal Infirm, New Lister Bldg,8-16 Alexandra Parade, Glasgow G31 2ER, Scotland
关键词
cancer; colorectal; inflammation; screening; SIR; TO-MONOCYTE RATIO; LYMPHOCYTE RATIO; TUMOR; SURVIVAL; MARKERS; INDEX;
D O I
10.1111/codi.16824
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: A raised systemic inflammatory response correlates with poorer colorectal cancer (CRC) outcomes. Faecal immunochemical test bowel screening aims to detect early-stage disease. We assessed the relationship between systemic inflammatory response, screen detection and CRC survival.Method: A retrospective, observational cohort study compared screen-detected and non-screen-detected CRC patients undergoing resection. Systemic inflammatory response was measured using lymphocyte/monocyte, neutrophil/lymphocyte and platelet/lymphocyte ratios (LMR, NLR, PLR). Covariables were compared using chi 2 testing and survival with Cox regression.Results: A total of 761 patients were included (326 screen-detected, 435 non-screen-detected). Screen-detected patients had lower systemic inflammatory response: low (<2.4) LMR (28.8% vs. 44.6%; P < 0.001), moderate (3-5) or high (>5) NLR (26.1% vs. 30.6%, P < 0.001; and 7.7% vs. 19.5%, P < 0.001) and high (>150) PLR (47.2% vs. 64.6%; P < 0.001). Median follow-up was 63 months. On univariate analysis, non-screen detection (hazard ratio [HR] 2.346, 95% CI 1.687-3.261; P < 0.001), advanced TNM (P < 0.001), low LMR (HR 2.038, 95% CI 1.514-2.742; P < 0.001), moderate NLR (HR 1.588, 95% CI 1.128-2.235; P = 0.008), high NLR (HR 2.382, 95% CI 1.626-3.491; P < 0.001) and high PLR (HR 1.827, 95% CI 1.326-2.519; P < 0.001) predicted poorer overall survival (OS). Non-screen detection (HR 2.713, 95% CI 1.742-4.226; P < 0.001), TNM (P < 0.001), low LMR (HR 1.969, 95% CI 1.340-2.893; P < 0.001), high NLR (HR 2.368, 95% CI 1.448-3.875; P < 0.001) and high PLR (HR 2.110, 95% CI 1.374-3.240; P < 0.001) predicted poorer cancer-specific survival (CSS). On multivariate analysis, non-screen detection (HR 1.698, 95% CI 1.152-2.503; P = 0.008) and low LMR (HR 1.610, 95% CI 1.158-2.238; P = 0.005) independently predicted poorer OS. Non-screen detection (HR 1.847, 95% CI 1.144-2.983; P = 0.012) and high PLR (HR 1.578, 95% CI 1.018-2.444; P = 0.041) predicted poorer CSS.Conclusion: Screen-detected CRC patients have a lower systemic inflammatory response. Non-screen detection and systemic inflammatory response (measured by LMR and PLR respectively) were independent predictors of poorer OS and CSS.
引用
收藏
页码:81 / 94
页数:14
相关论文
共 50 条
  • [31] Relationship between intestinal microbiota and colorectal cancer
    Cipe, Gokhan
    Idiz, Ufuk Oguz
    Firat, Deniz
    Bektasoglu, Huseyin
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 233 - 240
  • [32] Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
    Roxburgh, Campbell S. D.
    McMillan, Donald C.
    FUTURE ONCOLOGY, 2010, 6 (01) : 149 - 163
  • [33] Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival
    Hjortborg, Mats
    Edin, Sofia
    Boeckelman, Camilla
    Kaprio, Tuomas
    Li, Xingru
    Gkekas, Ioannis
    Hagstroem, Jaana
    Strigard, Karin
    Haglund, Caj
    Gunnarsson, Ulf
    Palmqvist, Richard
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] The clinical utility of the local inflammatory response in colorectal cancer
    Richards, Colin H.
    Roxburgh, Campbell S. D.
    Powell, Arfon G.
    Foulis, Alan K.
    Horgan, Paul G.
    McMillan, Donald C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 309 - 319
  • [35] Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
    E F Leitch
    M Chakrabarti
    J E M Crozier
    R F McKee
    J H Anderson
    P G Horgan
    D C McMillan
    British Journal of Cancer, 2007, 97 : 1266 - 1270
  • [36] Systemic Inflammatory Response in Gastric Cancer
    Yamashita, Hiroharu
    Katai, Hitoshi
    WORLD JOURNAL OF SURGERY, 2010, 34 (10) : 2399 - 2400
  • [37] Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
    Leitch, E. F.
    Chakrabarti, M.
    Crozier, J. E. M.
    McKee, R. F.
    Anderson, J. H.
    Horgan, P. G.
    McMillan, D. C.
    BRITISH JOURNAL OF CANCER, 2007, 97 (09) : 1266 - 1270
  • [38] LOCAL INFLAMMATORY RESPONSE IN COLORECTAL CANCER
    Laskowski, Pawel
    Klim, Beata
    Ostrowski, Karol
    Szkudlarek, Magdalena
    Litwiejko-Pietrynczak, Elzbieta
    Kitlas, Katarzyna
    Nienartowicz, Andrzej
    Dzieciol, Janusz
    POLISH JOURNAL OF PATHOLOGY, 2016, 67 (02) : 163 - 171
  • [39] The Relationship Between Tumor Glucose Metabolism and Host Systemic Inflammatory Responses in Patients with Cancer: A Systematic Review
    Dolan, Ross D.
    McLees, Naomi G.
    Irfan, Ahmer
    McSorley, Stephen T.
    Horgan, Paul G.
    Colville, David
    McMillan, Donald C.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (04) : 467 - 471
  • [40] Re: Ishizuka et al., Systemic Inflammatory Response Predicts Postoperative Outcome in Patients With Liver Metastases From Colorectal Cancer
    Roxburgh, Campbell
    McMillan, Donald
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (07) : 616 - 616